The pharma industry claims lower prescription drug prices will mean less access to new medication for Canadians. It’s an old threat that pits profits against patients’ rights to affordable drugs.
Academic rigor, journalistic flair
Articles on Pharmaceutical companies
Displaying all articles
The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.
Boosters and vaccinating children mean we’re relying on two pharmaceutical companies to supply Australia’s COVID vaccines. That needs to change.
Western pharmaceutical companies can’t stop supplying essential medicines to Russia, but they can cease other business.
Generic drug names are often long, but they can tell doctors what type of medicine it is and how it works. But it’s brand names that appear first and most prominently in Health Canada materials.
When drugs are taken off the market because they are either unsafe or don’t work, do pharma companies admit that there are problems? Or do they deny the evidence?
If no action is taken to address antibiotic resistance, infections from multidrug-resistant bacteria could cause 10 million deaths each year by 2050.
A private market should have no place in the rollout of a COVID vaccine.
Drug companies normally use patents to protect new treatments.
Previously secret documents and data make it clear that many companies engaged in the distribution of prescription painkillers either skirted or ignored their legal obligations for years.
The first study to assess the carbon footprint of the pharmaceutical industry finds that it is far from green.
The interests of pharmaceutical companies and public health are not the same. Industry dollars can distort research agendas, while framing health challenges and solutions in ways that benefit corporations.
It takes about three years for safety problems to be identified in new drugs, newer drugs are almost always more expensive, and yet Canadian doctors still hand out hundreds of thousands of samples.
The end of effective antibiotics will be frightening. Life expectancy will fall dramatically and people of all ages will die from illnesses that we are used to treating with $10 worth of pills.
Nevada plans to use a new drug protocol for executing Scott Dozier, who murdered a 22-year-old. A scholar explains why this is problematic.
Top contributors
-
Professor Emeritus of Health Policy and Management, York University, Canada
-
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
-
Reader in Intellectual Property Law, City, University of London
-
William Nelson Cromwell Professor of Jurisprudence and Political Science, Amherst College
-
Associate professor, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Professor of Biochemistry and Biomedical Sciences, McMaster University
-
Director of the Bioethics Program and affiliate faculty in Law and International Affairs, Penn State
-
Associate Professor & Chair of Eco-Entrepreneurship, McMaster University
-
Professor of Law, Indiana University
-
Interim Dean/Professor-College of Science, Rochester Institute of Technology
-
Henry Baldwin Professorial Research Fellow in Health System Sustainability, University of Tasmania
-
Associate Professor of Aesthetics and Art Theory, Nanjing University
-
PhD Candidate and Pharmacist, University of Sydney
-
Adjunct Lecturer, School of Pharmacy, University of Sydney
-
Assistant Professor, Department of Family and Community Medicine, University of Toronto
